NAMED PATIENT PROGRAM USE OF PEDMARK® TO REDUCE THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH VARIED SOLID TUMORS için istatistikler
Toplam ziyaret
| views | |
|---|---|
| NAMED PATIENT PROGRAM USE OF PEDMARK® TO REDUCE THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH VARIED SOLID TUMORS | 10 |
Aylık toplam ziyaret
| views | |
|---|---|
| Haziran 2025 | 0 |
| Temmuz 2025 | 0 |
| Ağustos 2025 | 0 |
| Eylül 2025 | 0 |
| Ekim 2025 | 0 |
| Kasım 2025 | 0 |
| Aralık 2025 | 0 |
